Hypnotic Medications Linked to Suicide Risk
A recent review found that hypnotic medications are associated with risks of suicide and suicidal ideation.
Systematic Review Finds Antidepressants Double the Risk for Agitation and Violence in Healthy Volunteers
The Nordic Cochrane Center conducted a systematic review of existing research trials on antidepressants and found that the drugs doubled the risk of feelings...
Use of Antidepressants Linked to Diabetes
Selective serotonin reuptake inhibitors (such as Prozac and Zoloft) are the most commonly prescribed medication for depression. SSRIs have long been associated with an...
Clinical Trials Underreport Harms of Antidepressant Medications
A group of researchers recently found serious bias in the reporting of harm due to adverse events in antidepressant medication clinical trials. They report...
New Study Casts Doubt on Efficacy of Ketamine for Depression
A new study, published this month in the Journal of Affective Disorders, investigated the effectiveness of weekly intravenous ketamine injections as a treatment for...
“Medicating a Prophet”
In the New York Times Sunday Review, Irene Hurford, a psychiatrist, reflects on the ethics of forced treatment for psychosis. “As doctors,” she writes,...
The Mental Health Reform Act of 2016 (SB 2680) Would Be a Huge Step...
There is indeed a crisis in the mental health business. The crisis derives from psychiatry's spurious and self-serving premise that all significant problems of thinking, feeling, and/or behaving are brain illnesses that are correctable by psychiatric drugs.
Evolution or Revolution? Why Western Psychiatry Won’t Change by Incremental Steps
...but how realistic is it to expect that the biological skew of Western psychiatry can be sustainably changed one small step at a time?
German Psychologists Declare “the Drugs Don’t Work”
Jürgen Margraf and Silvia Schneider, both well-known psychologists at the University of Bochum in Germany, claim that psychotropic drugs are no solution to mental...
STOP or GO? Tapering Pregnant Women off of Antidepressants
A team in the Netherlands is currently investigating the effects of tapering off of antidepressants known as selective serotonin reuptake inhibitors (SSRIs) during pregnancy....
Ghostwriting has a New Name but Same Problems
A new paper, published in the British Medical Journal, explains how the pharmaceutical industry has publicly denounced ghostwriting while still finding ways to engage...
CDC Advises Nonopioid Treatments for Chronic Pain
Primary care clinicians and mental health providers face a particular set of challenges when treating individuals with chronic pain. These problems are compounded by...
The ADHD Drug Epidemic: Addiction, Abuse, and Death
A new analysis of FDA data, published on September 10th by the Milwaukee Journal Sentinel/MedPage Today, reveals the dangers of the common prescription of...
Psychiatric Drug Ads Lead to More Prescriptions and Worse Treatment
A new analysis published in the The Journal of Clinical Psychiatry investigates the public health effects of direct-to-consumer advertisements for psychiatric drugs. The researchers...
“Canadian Patients Fight Forced Electroshock”
"A retired nurse, a Harvard-educated musician and others sued British Columbia this week, claiming it forcibly subjects mental health patients to electroconvulsive therapy and...
“FDA Panel Votes to Remove Serious Warning from Pfizer’s Smoking Cessation Pill”
This week an FDA advisory panel decided to remove warnings of serious psychiatric side effects from the Chantix product label. “In making its recommendation,...
“FDA questions Pfizer Study of Chantix Psychiatric Effects”
Pfizer is petitioning the FDA to remove the black box warning for Chantix which focuses on neuropsychiatric side-effects like suicidality and depression. The regulators...
Garbage In–Garbage Out: Systematic Reviews and Meta-Analyses can tell us a Flawed Story
Well known Stanford University researcher John Ioannidis published a new paper this week criticizing the use and production of systematic reviews and meta-analyses, often...
Review Finds Link Between Recession and Mental Health Issues
A literature review published in BMC Public Health by researchers from Portugal and the Czech Republic summarizes results from 101 studies investigating the effect...
Petition Calls on Pharma Companies to Offer Tapering Kits for Depression and Anxiety Drugs
A change.org petition out of the United Kingdom is addressing the extreme difficulty faced by people who attempt to taper off of antidepressants and...
Ioannidis Questions Strength of Psychology and Neuroscience Literature
Last week, well-known Stanford scientist John Ioannidis and his colleague Denes Szucs released a new analysis online. They examined research published in eighteen prominent...
ECT Survivors Take On the FDA
In December, the FDA proposed down-classifying the device used in electroshock treatment (ECT), which would loosen regulations and potentially make ECT more widely available...
Clinton Releases Mental Health Plan
Today, Hillary Clinton’s campaign released their plan for addressing mental health care in the United States. The plan calls for a full integration of...
“Antidepressants Make it Harder to Empathize, Harder to Climax, and Harder to Cry”
Psychiatrist Julie Holland explains how antidepressants can medicate away important feelings and experiences in a video for Big Think.
Video →
“Many Clinical Trials’ Findings Never Get Published. Here’s Why That’s Bad”
STAT’s watchdogs, Ivan Oransky and Adam Marcus, explain why unpublished studies for drug makers and researchers “put young patients at risk, particularly if those...
